Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(6 sites)
France
Chu Dijon Bourgogne, Dijon Institut de Cancérologie de Bourgogne, Dijon Chu de Limoges - Dupuytren, Limoges Centre Hospitalier de Saint Malo, St-Malo Age range
18 Years and older
Last updated September 2025